Aktuellt
SENASTE
Redeye retains its positive view of Transtema despite lowering our forecasts and Base Case. While management highlighted a weaker 5G market in the Q1 2023 report, the situation seems to have worsened. Despite raising some questions regarding the UBConnect acquisition, management must handle a downturn, and we believe the long-term prospects are solid. Also, even with our estimate cuts, Transtema is trading at a low valuation multiple in relative and absolute terms.
LÄS MER
